Skip to content

Return on equity at other companies

AMN Healthcare logo
AMN HealthcareAMN
-4.5%-2.0pp
Teladoc Health logo
Teladoc HealthTDOC
-12.4%-5.4pp
Cencora logo
CencoraCOR
130.6%-99.8pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
15.3%-0.1pp
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
10.7%+0.9pp
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
48.6%+27.9pp

Other financials

Income statement

See full
Revenue$241.1M-17.8%
Operating income-$4.2M-325%
Net income-$4.3M-771%
EPS (diluted)-$0.14-600%

Balance sheet

See full
Cash & equivalents$105.6M+30.8%
Total debt$2.0M-38.3%
Total equity$312.8M-25.2%
Total assets$451.1M-21.7%

Cash flow

See full
Operating cash flow$4.8M-16.1%
CapEx$1.5M-22.7%
Free cash flow$3.3M-12.8%

Valuation

See full
Market cap$426.12M-6.5%
Enterprise value$322.58M-14.7%
P/S0.4×+0.1×

Profitability

See full
Operating margin-8.7%-11.4pp
Net margin-9.8%-11.8pp
FCF margin4%-4.9pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio3.3×+0.3×

Where this comes from

Calculated from Cross Country Healthcare’s reported figures.

Based on trailing twelve months.

The official record: Cross Country Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cross Country Healthcare's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cross Country Healthcare's return on equity?
Cross Country Healthcare (CCRN) reported return on equity of -27% in Q1 2026.
How has Cross Country Healthcare's return on equity changed year-over-year?
Cross Country Healthcare's return on equity decreased by 569.8% year-over-year, from -4% to -27%.
What is the long-term trend for Cross Country Healthcare's return on equity?
Over 5 years (2020 to 2025), Cross Country Healthcare's return on equity has grown at a 25.6% compound annual growth rate (CAGR), from -8.2% to -25.6%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.